Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Heartflow (HTFL) Gains from Investment Securities (2024 - 2025)

Heartflow has reported Gains from Investment Securities over the past 2 years, most recently at $41.2 million for Q4 2025.

For Q4 2025, Gains from Investment Securities rose 150.21% year-over-year to $41.2 million; the TTM value through Dec 2025 reached $90.6 million, changed N/A, while the annual FY2025 figure was $469508.0, 94.5% down from the prior year.
Gains from Investment Securities for Q4 2025 was $41.2 million at Heartflow, up from $32.1 million in the prior quarter.
Over five years, Gains from Investment Securities peaked at $41.2 million in Q4 2025 and troughed at $585000.0 in Q3 2024.